Hánah N. Rier

Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy

Hánah N. Rier, Agnes Jager, Stefan Sleijfer et al. · The Breast · 2016 · 146 citations · Full text

Medicine, Oncology, Radiology +15

Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer

Hánah N. Rier, Agnes Jager, Stefan Sleijfer et al. · Breast Cancer Research and Treatment · 2017 · 47 citations

Medicine, Oncology, Pharmacology +17

Prognostic impact of low muscle mass and low muscle density in patients with diffuse large B-cell lymphoma

Hánah N. Rier, H. H. S. Kharagjitsing, Joost van Rosmalen et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 26 citations · Full text

Medicine, Oncology, Radiology +17

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

Nathalie I. Bouwer, Tessa G. Steenbruggen, Joost van Rosmalen et al. · Breast Cancer Research and Treatment · 2021 · 26 citations · Full text

Medicine, Cardiology, Oncology +15

Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?

Tessa G. Steenbruggen, Nathalie I. Bouwer, Carolien H. Smorenburg et al. · Breast Cancer Research and Treatment · 2019 · 24 citations

Medicine, Oncology, Radiology +13